Gimv NV (LON:0EKR)
London · Delayed Price · Currency is GBP · Price in EUR 44.90
-0.50 (-1.10%)
At close: Oct 17, 2025
Gimv NV Revenue
In the fiscal year ending March 31, 2025, Gimv NV had annual revenue of 300.94 million EUR with 3.07% growth. Gimv NV had revenue of 113.63 million in the half year ending March 31, 2025, with 135.72% growth.
Revenue
300.94M EUR
Revenue Growth
+3.07%
P/S Ratio
5.73
Revenue / Employee
3.20M EUR
Employees
94
Market Cap
1.44B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 300.94M | 8.98M | 3.07% |
| Mar 31, 2024 | 291.96M | 294.38M | -12,184.48% |
| Mar 31, 2023 | -2.42M | -254.68M | -100.96% |
| Mar 31, 2022 | 252.27M | -78.75M | -23.79% |
| Mar 31, 2021 | 331.02M | 183.75M | 124.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |